As of Feb 03, 2025, CVS Health Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $371.4. This suggests it may be undervalued by 563.9% compared to its current price of around $56.0, using a WACC of 3.9% and growth rates of 3.0%.
As of Feb 03, 2025, CVS Health Corporation's Weighted Average Cost of Capital (WACC) is approximately 3.9%.
As of Feb 03, 2025, CVS Health Corporation's Enterprise Value (EV) is approximately $535.6B. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.